Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Divestments (2018 - 2021)

Pediatrix Medical (MD) has disclosed Divestments for 4 consecutive years, with $2.4 million as the latest value for Q1 2021.

  • On a quarterly basis, Divestments rose 180.1% to $2.4 million in Q1 2021 year-over-year; TTM through Dec 2021 was $2.4 million, a 99.73% decrease, with the full-year FY2021 number at $2.4 million, down 99.73% from a year prior.
  • Divestments was $2.4 million for Q1 2021 at Pediatrix Medical, down from $870.8 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $870.8 million in Q4 2020 to a low of -$22.8 million in Q4 2018.
  • A 4-year average of $102.9 million and a median of $5.3 million in 2020 define the central range for Divestments.
  • Peak YoY movement for Divestments: soared 770.77% in 2019, then crashed 170.54% in 2020.
  • Pediatrix Medical's Divestments stood at -$22.8 million in 2018, then soared by 770.77% to $152.7 million in 2019, then skyrocketed by 470.27% to $870.8 million in 2020, then crashed by 99.73% to $2.4 million in 2021.
  • Per Business Quant, the three most recent readings for MD's Divestments are $2.4 million (Q1 2021), $870.8 million (Q4 2020), and -$6.0 million (Q3 2020).